CMTx Biotech is a clinical-stage biopharmaceutical company that is developing an orally administered small molecule for the treatment of sepsis patients at risk of Acute Respiratory Distress Syndrome (ARDS) and/or Multiple Organ Dysfunction Syndrome (MODS), including those infected with SARS-CoV-2 (COVID-19).

Biotechnology

CMTx Biotech

Joseph Scaduto

Joann Wilson

James Keane

Christopher Czura

Lorne Golub

Sonny Granger

The leadership team at CMTx Biotech has a wealth of experience in the healthcare and pharmaceutical industries, as well as in business development, strategy, and investment. The team is led by CEO Connexin Therapeutics Ltd., and includes an instructor at EBD Academy, the director of business development at Panion Animal Health, and the head of strategy at PicketNow.com. The team also has experience in real estate development, finance, and parenting solutions.

Leadership Team

Board of Directors

Founding Team

Leadership Team

About

Team members

Other teams at CMTx Biotech

Board of Directors

Founding Team